Since the mechanism of these changes is independent of the catalytic function of ALDOA, we conclude that overexpression of ALDOA in cancerous cells is not related to their high glycolytic requirements but represents an adaptation by which metastatic cancer cells ensure integrity of their actin cytoskeleton while undergoing the epithelial–mesenchymal transition. Here, ALDOA is linked to cancer.